Health Care · Euronext Paris · FYE 12-31 · no price history on file
Mkt cap $285M
Price
Price series unavailable — No prices available for CVX.PA in [1900-01-01, 2026-07-30]. This symbol may require bring-your-own-key (BYOK) data.
At a glance
No fair-value, short-interest or ownership figures on file for CVX.PA.
Key fundamentalsFY 2025
| Sales (TTM)€0 |
| Earnings (TTM)-€25.0M |
| ROE−138.6% |
| ROIC−52.3% |
| Debt / equity3.98× |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
Trailing returns
No return windows available for CVX.PA.
Risk
No risk analytics available for CVX.PA.
Top institutional holders13F 2026-Q1
No 13F holders on file for CVX.PA.
Latest reported quarters
No reported quarters on file for CVX.PA.
Basis & disclosures
- End-of-day only. Every price on this sheet is a stored CLOSE. Nothing here is live, intraday or delayed-real-time, and the sheet does not update after it is printed.
- Nothing is imputed. A figure that is not in the underlying filing or feed renders as “—”. We never fill a gap with an estimate, a peer median or a carried-forward value.
- Mixed as-of dates by design. Prices are at the last close; fundamentals are at the latest reported fiscal period; 13F ownership is at the latest filed quarter (45+ days in arrears); short interest is the latest FINRA settlement. Each block states its own basis above.
- Not investment advice. Model fair values, reverse-DCF grades and confidence labels are the output of published, disclosed methods on public filings — they are analysis, not a recommendation, a price target or a solicitation.
- Fundamentals and ownership derive from SEC EDGAR (and equivalent foreign registers); prices from a licensed end-of-day vendor, shown under a neutral source label. Full methodology at spzco.com/methodology.
